Clinical Trial Update: A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ATHX-105 Phosphate for weight loss in obesity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ATHX-105 Phosphate (ATHX-105 phosphate)

Snippet

Sponsor: Healios K.K. | Conditions: Obesity | Phase 2 | Status: WITHDRAWN